Report cover image

Global Antitussive Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 190 Pages
SKU # APRC20278741

Description

Summary

According to APO Research, The global Antitussive Drugs market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Antitussive Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Antitussive Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Antitussive Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Antitussive Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Antitussive Drugs include Alkem Laboratories, Cipla, Glenmark Pharmaceuticals, Toray Industries, Zydus Cadila, AstraZeneca, Pfizer, Merck and Novartis, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Antitussive Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Antitussive Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Antitussive Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antitussive Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Antitussive Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Antitussive Drugs sales, projected growth trends, production technology, application and end-user industry.

Antitussive Drugs Segment by Company

Alkem Laboratories
Cipla
Glenmark Pharmaceuticals
Toray Industries
Zydus Cadila
AstraZeneca
Pfizer
Merck
Novartis
Johnson & Johnson
Sanofi
Antitussive Drugs Segment by Type

Centrally Acting Antitussive Drugs
Locally Acting Antitussive Drugs
Antitussive Drugs Segment by Application

Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Antitussive Drugs Segment by Region

North America

United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Middle East & Africa

Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antitussive Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antitussive Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antitussive Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antitussive Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antitussive Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antitussive Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Antitussive Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

190 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Antitussive Drugs Market Size, 2020 VS 2024 VS 2031
1.3 Global Antitussive Drugs Market Size Estimates and Forecasts (2020-2031)
1.4 Global Antitussive Drugs Sales Estimates and Forecasts (2020-2031)
1.5 Global Antitussive Drugs Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Antitussive Drugs Market Dynamics
2.1 Antitussive Drugs Industry Trends
2.2 Antitussive Drugs Industry Drivers
2.3 Antitussive Drugs Industry Opportunities and Challenges
2.4 Antitussive Drugs Industry Restraints
3 Antitussive Drugs Market by Manufacturers
3.1 Global Antitussive Drugs Revenue by Manufacturers (2020-2025)
3.2 Global Antitussive Drugs Sales by Manufacturers (2020-2025)
3.3 Global Antitussive Drugs Average Sales Price by Manufacturers (2020-2025)
3.4 Global Antitussive Drugs Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Antitussive Drugs Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Antitussive Drugs Manufacturers, Product Type & Application
3.7 Global Antitussive Drugs Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Antitussive Drugs Market CR5 and HHI
3.8.2 Global Top 5 and 10 Antitussive Drugs Players Market Share by Revenue in 2024
3.8.3 2024 Antitussive Drugs Tier 1, Tier 2, and Tier 3
4 Antitussive Drugs Market by Type
4.1 Antitussive Drugs Type Introduction
4.1.1 Centrally Acting Antitussive Drugs
4.1.2 Locally Acting Antitussive Drugs
4.2 Global Antitussive Drugs Sales by Type
4.2.1 Global Antitussive Drugs Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Antitussive Drugs Sales by Type (2020-2031)
4.2.3 Global Antitussive Drugs Sales Market Share by Type (2020-2031)
4.3 Global Antitussive Drugs Revenue by Type
4.3.1 Global Antitussive Drugs Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Antitussive Drugs Revenue by Type (2020-2031)
4.3.3 Global Antitussive Drugs Revenue Market Share by Type (2020-2031)
5 Antitussive Drugs Market by Application
5.1 Antitussive Drugs Application Introduction
5.1.1 Hospital Pharmacies
5.1.2 Online Pharmacies
5.1.3 Retail Pharmacies
5.2 Global Antitussive Drugs Sales by Application
5.2.1 Global Antitussive Drugs Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Antitussive Drugs Sales by Application (2020-2031)
5.2.3 Global Antitussive Drugs Sales Market Share by Application (2020-2031)
5.3 Global Antitussive Drugs Revenue by Application
5.3.1 Global Antitussive Drugs Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Antitussive Drugs Revenue by Application (2020-2031)
5.3.3 Global Antitussive Drugs Revenue Market Share by Application (2020-2031)
6 Global Antitussive Drugs Sales by Region
6.1 Global Antitussive Drugs Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Antitussive Drugs Sales by Region (2020-2031)
6.2.1 Global Antitussive Drugs Sales by Region (2020-2025)
6.2.2 Global Antitussive Drugs Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Antitussive Drugs Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Antitussive Drugs Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Antitussive Drugs Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Antitussive Drugs Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Antitussive Drugs Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Antitussive Drugs Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Antitussive Drugs Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Antitussive Drugs Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Antitussive Drugs Revenue by Region
7.1 Global Antitussive Drugs Revenue by Region
7.1.1 Global Antitussive Drugs Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Antitussive Drugs Revenue by Region (2020-2025)
7.1.3 Global Antitussive Drugs Revenue by Region (2026-2031)
7.1.4 Global Antitussive Drugs Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Antitussive Drugs Revenue (2020-2031)
7.2.2 North America Antitussive Drugs Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Antitussive Drugs Revenue (2020-2031)
7.3.2 Europe Antitussive Drugs Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Antitussive Drugs Revenue (2020-2031)
7.4.2 Asia-Pacific Antitussive Drugs Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Antitussive Drugs Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Antitussive Drugs Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Alkem Laboratories
8.1.1 Alkem Laboratories Comapny Information
8.1.2 Alkem Laboratories Business Overview
8.1.3 Alkem Laboratories Antitussive Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Alkem Laboratories Antitussive Drugs Product Portfolio
8.1.5 Alkem Laboratories Recent Developments
8.2 Cipla
8.2.1 Cipla Comapny Information
8.2.2 Cipla Business Overview
8.2.3 Cipla Antitussive Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Cipla Antitussive Drugs Product Portfolio
8.2.5 Cipla Recent Developments
8.3 Glenmark Pharmaceuticals
8.3.1 Glenmark Pharmaceuticals Comapny Information
8.3.2 Glenmark Pharmaceuticals Business Overview
8.3.3 Glenmark Pharmaceuticals Antitussive Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Glenmark Pharmaceuticals Antitussive Drugs Product Portfolio
8.3.5 Glenmark Pharmaceuticals Recent Developments
8.4 Toray Industries
8.4.1 Toray Industries Comapny Information
8.4.2 Toray Industries Business Overview
8.4.3 Toray Industries Antitussive Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Toray Industries Antitussive Drugs Product Portfolio
8.4.5 Toray Industries Recent Developments
8.5 Zydus Cadila
8.5.1 Zydus Cadila Comapny Information
8.5.2 Zydus Cadila Business Overview
8.5.3 Zydus Cadila Antitussive Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Zydus Cadila Antitussive Drugs Product Portfolio
8.5.5 Zydus Cadila Recent Developments
8.6 AstraZeneca
8.6.1 AstraZeneca Comapny Information
8.6.2 AstraZeneca Business Overview
8.6.3 AstraZeneca Antitussive Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 AstraZeneca Antitussive Drugs Product Portfolio
8.6.5 AstraZeneca Recent Developments
8.7 Pfizer
8.7.1 Pfizer Comapny Information
8.7.2 Pfizer Business Overview
8.7.3 Pfizer Antitussive Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Pfizer Antitussive Drugs Product Portfolio
8.7.5 Pfizer Recent Developments
8.8 Merck
8.8.1 Merck Comapny Information
8.8.2 Merck Business Overview
8.8.3 Merck Antitussive Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Merck Antitussive Drugs Product Portfolio
8.8.5 Merck Recent Developments
8.9 Novartis
8.9.1 Novartis Comapny Information
8.9.2 Novartis Business Overview
8.9.3 Novartis Antitussive Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Novartis Antitussive Drugs Product Portfolio
8.9.5 Novartis Recent Developments
8.10 Johnson & Johnson
8.10.1 Johnson & Johnson Comapny Information
8.10.2 Johnson & Johnson Business Overview
8.10.3 Johnson & Johnson Antitussive Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Johnson & Johnson Antitussive Drugs Product Portfolio
8.10.5 Johnson & Johnson Recent Developments
8.11 Sanofi
8.11.1 Sanofi Comapny Information
8.11.2 Sanofi Business Overview
8.11.3 Sanofi Antitussive Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Sanofi Antitussive Drugs Product Portfolio
8.11.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Antitussive Drugs Value Chain Analysis
9.1.1 Antitussive Drugs Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Antitussive Drugs Production Mode & Process
9.2 Antitussive Drugs Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Antitussive Drugs Distributors
9.2.3 Antitussive Drugs Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.